82% of MSS/EMT-type tumors are diffuse type with high expression of RAI14 (Fig. EV5G), and these patients expressing high RAI14 had a much worse prognosis than MSS/EMT-type patients expressing low RAI14 (Fig. EV5K). This evidence concerns the gene RAI14 and Marinesco-Sjogren syndrome.